Gene Query: GOSR2

Dataset Description Geneva Score
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 140.59
Statins modulate endothelial transcriptional profile by inhibiting EZH2 25.65
Gene expression analysis of the impact of TDP-43 knockout in human cells. 19.59
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 17.8
MYCi361 regulates MYC target genes 17.71
RNAseq Analysis in glioblastoma cells treated with Mepazine 15.14
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 14.76
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.98
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 12.24
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 12.03
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 11.49
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 11.07
The Human Testis Cell Atlas via Single-cell RNA-seq 10.74
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 10.36
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 10.18
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 10.04
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 9.52
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.4
Patient-derived luminal breast cancer xenografts with progestins 9.4
Gene expression analysis of dengue-infected cells 9.14
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.82
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.72
RNA-seq in transgenic cells 8.57
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 8.56
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 8.49
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 8.49
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 8.39
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 8.33
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 7.9
RNA-seq of IL-4 stimulated human keratinocytes 7.79
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 7.61
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.42
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.35
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.35
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 7.29
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 7.25
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 7.25
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.15
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 7.1
Cleavage Factor Im as a key regulator of 3’ UTR length 7.07
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.04
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 6.97
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 6.9
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.84
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.84
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 6.77
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 6.74
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.7
Functional role of SLIT2 and ROBO1 in trophoblasts 6.61
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.56
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.55
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.49
4sUDRB-seq: measuring transcription elongation and initiation genomewide 6.37
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 6.35
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 6.25
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 6.24
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.22
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 6.21
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 6.21
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.14
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.08
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.04
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.03
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.02
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.99
T47D RNA-seq and ChrRNA-seq data 5.99
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 5.97
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 5.97
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 5.78
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 5.75
Cajal bodies are linked to genome conformation [RNA-Seq] 5.74
Cajal bodies are linked to genome conformation 5.74
EP400 is required for Max and MCPyV mediated gene activation 5.7
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 5.67
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.66
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.65
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.64
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.49
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.49
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.47
Selective suppression of endothelial cytokine production by progesterone receptor 5.47
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 5.41
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.39
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.32
RNA Seq of HMVEC under hypoxia 5.32
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.31
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.3
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.3
Effect of disulfiram treatment on pediatric high grade glioma 5.28
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.25
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 5.22
Transcriptional responses of human insulinoma cells to acute cytokine exposure 5.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.15
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.11
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 5.09
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.07
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 4.98
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.97
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.95
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.95
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.95
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.91
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.89
Dtx3L and Androgen Signaling in Prostate Cancer 4.76
TFAP2C signalling in human fibroblasts 4.64
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.56
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.55
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 4.52
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 4.51
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.51
Transcriptomic analyssis following EHMT1/2 inhibition 4.5
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.48
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.47
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.47
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.44
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.37
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.37
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.32
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.29
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.29
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.2
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.2
Neonatal and adult human testis defined at the single-cell level 4.2
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.2
Trans-differentiation of human adult peripheral blood T cells into neurons 4.15
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.09
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.05
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 4.05
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.04
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.04
X-Ray induced DNA-Hydroxymethylation changes 4.03
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.01
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.0
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.99
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.99
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.98
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.97
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 3.96
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 3.96
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 3.96
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 3.94
A single cell reference map for human blood and tissue T cell activation 3.91
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.89
m6A-dependent regulation of messenger RNA stability 3.88
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.88
IL-33 activates tumor stroma to promote intestinal polyposis 3.87
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.86
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.86
Regulation of protein translation during mitosis 3.86
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.85
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 3.83
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.83
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.82
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.81
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 3.8
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.77
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.76
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 3.66
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 3.66
Genome-wide chromatin analysis of Ewing sarcoma 3.62
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.62
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.6
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 3.59
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 3.59
Neurofibroma 3.59
Ectoderm specification of H1 human embryonic stem cells 3.56
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.55
Human Treg IL-12 stimulation 3.55
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.54
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.53
DART-seq: an antibody-free method for global m6A detection 3.52
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.52
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.5
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.49
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.48
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.48
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.44
Aneuploidy triggers an immune response 3.43
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 3.42
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.42
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.41
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.4
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.38
4sU-seq of HFF exposed to salt and heat stress 3.38
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.37
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.36
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.36
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.33
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.33
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.33
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.32
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.32
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.32
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.31
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.31
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.3
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 3.3
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 3.3
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.29
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.27
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 3.25
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.23
Global transcriptome analysis of HAP1 cells 3.22
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.22
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.21
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 3.21
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 3.21
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 3.2
An optimization system for isolating and sequencing of single human colon cancer cells 3.18
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.18
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.18
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 3.17
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 3.17
Gene expression in PANC1 cells treated with Rakicidin 3.15
Cerebellar differentiation in Ataxia-Telangiectasia 3.15
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.14
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.11
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.11
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.1
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.1
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 3.1
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 3.09
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.06
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.05
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.04
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.01
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.01
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.96
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.96
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.96
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.95
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 2.95
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.93
LncRNA-GAS5 negative regulation of YAP-target genes expression 2.92
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.85
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.85
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.81
IRF1 regulates IFN dependent and independent gene expression 2.8
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.8
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 2.79
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.79
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.78
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 2.77
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.76
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.76
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 2.75
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.74
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.73
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 2.71
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 2.7
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.7
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.7
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.69
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.69
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.62
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.62
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.61
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.57
RNA-seq analyisis of PUM2 knockout cells 2.55
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 2.55
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 2.55
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 2.55
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 2.54
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.51
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.51
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 2.49
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.49
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.48
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.48
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 2.47
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 2.47
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.47
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.47
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.44
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.43
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.42
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.41
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.37
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.37
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.37
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.36
UV_24h_GRO-Seq 2.35
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.31
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.28
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.26
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.2
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.2
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 2.19
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.17
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.14
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.14
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.13
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.12
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.11
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.11
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.11
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.09
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.09
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 2.08
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 2.08
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.08
Functional role of CPPED1 in trophoblasts. 2.07
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.04
Genome-wide analysis of Dengue virus 2 infected cells 2.04
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.02
Real-time observation of light-controlled transcription in living cells 2.01
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.99
Stem and effector CD8 T-cells from human cancers 1.99
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.99
miRNAs affected by antagomiR-17 treatment 1.97
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.95
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 1.94
The MEF2B Regulatory Network - RNA-seq data 1.9
The MEF2B Regulatory Network 1.9
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.88
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.87
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.87
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.87
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.83
Identification of global XBP1s target gene expression in human prostate cancer cells 1.83
RNA-sequencing of healthy human skeletal myocytes 1.82
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.82
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.81
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.8
DRB/GRO-Seq -/+ UV 1.8
Landscape and variation of RNA secondary structure across the human transcriptome 1.78
The bromodomain protein BRD4 regulates splicing during heat shock 1.68
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.68
Functional significance of the HIV-1 Tat signature amino acid residues 1.65
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.64
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.64
O-glcnAc reprograms cellular energetics 1.63
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.62
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.62
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.61
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.6
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.56
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.53
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.53
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.53
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.53
MAIT cell RNA sequencing 1.53
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.52
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.5
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.49
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.49
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.46
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.46
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.43
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.43
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.41
Identification of a LIF-responsive replication-competent human β cell 1.41
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.39
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.37
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.36
Identification of differentially expressed genes between senescence and senescence bypass cells 1.36
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.34
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.34
RNA-seq data 1.34
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.33
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.33
Differential gene expression of human melanoma cells [RNA-seq] 1.33
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.29
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 1.29
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.29
The Genetic Landscape of Diamond-Blackfan Anemia 1.25
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.25
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.24
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.23
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.23
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.23
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.23
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.22
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.21
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.2
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.16
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.16
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.16
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.16
Discovering human diabetes-risk gene function with genetics and physiological assays 1.15
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.11
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.09
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 1.08
HEK293 TFAM Knockout Expression Study 1.07
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.06
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.05
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.04
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.04
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.03
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.02
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.0
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.98
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.97
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.96
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.95
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 0.94
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.91
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.91
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.91
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.88
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.87
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.85
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.84
p53 activity results in DNA replication fork processivity 0.82
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.82
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.81
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.81
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.81
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.8
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.79
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.78
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.77
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.75
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.75
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.74
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.74
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.72
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.7
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.7
Human Treg NaCl stimulation 0.7
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.69
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.68
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.67
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.67
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.67
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.66
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.66
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.62
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.62
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.6
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 0.58
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.57
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.56
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.55
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.53
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.52
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.52
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.51
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.49
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.49
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.48
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.48
Direct Isolation and Characterization of Human Nephron Progenitors. 0.42
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.42
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.42
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.41
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.41
Investigate A2M treatment on human prostate cancer xenograft in mice 0.39
Investigate A2M treatment on human prostate cancer and mouse liver 0.39
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.35
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.35
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.31
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.3
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.3
EGR1-controlled transcriptome of T HESCs 0.29
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.27
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.27
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.27
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.26
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.26
Loss of CREBBP results in gene expression repression in lymphoma cells 0.26
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.25
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.25
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.24
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.24
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.24
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.23
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.21
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.21
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.2
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.2
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.19
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.19
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.19
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.19
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.16
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.16
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.16
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.15
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.11
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.11
Preclinical model of obesity and ER-positive breast cancer 0.1
RNA editing in nascent RNA affects pre-mRNA splicing 0.1
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.09
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.09
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.08
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.05
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.04
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.02
Function and hormonal regulation of GATA3 in human first trimester placentation 0.02
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.02
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation